logo
Select company
Select metric
$ 61KNet Cash Flow - Financing
VS
Market
47
Sector
69
Industry
82
History
74
$ 8.69Close
$ 5.27 - $ 22.6 52-Week Range
Ticker Information

Ticker

PASG

Company Name

PASSAGE BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PASSAGE BIO INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PASG - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 61K
3/31/2025$ 132K
12/31/2024$ 8.87M
9/30/2024$ 8.87M
6/30/2024$ 8.87M
3/31/2024$ 8.88M
12/31/2023$ 135K
9/30/2023$ -499K
6/30/2023$ -907K
3/31/2023$ -1.4M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PASSAGE BIO INC's latest trailing twelve months (TTM) CF - Financing stands at $ 228.75M.
  • Over the past 5 years, PASSAGE BIO INC's average CF - Financing has been $ 48.72M.
  • The median CF - Financing for PASSAGE BIO INC during this period was $ 1.07M
  • PASSAGE BIO INC reached its highest CF - Financing over the past 5 years at $ 228.75M.
  • The lowest CF - Financing recorded by PASSAGE BIO INC in the same timeframe $ -1.4M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

PASG - Net Cash Flow - Financing, Last 5 years

$ -1.4M

Minimum

Mar 31, 2023

$ 228.75M

Maximum

Dec 31, 2020

$ 48.72M

Average

$ 1.07M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.85M with a standard deviation of $ 119.31M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.85M
median$ 305K
std$ 119.31M